Skip to main content
. 2024 Jan 18;26:13. doi: 10.1186/s13058-024-01768-y

Fig. 3.

Fig. 3

Progression impact of ESR1 and PIK3CA concentration and mutations detected in cell-free DNA (cfDNA) samples. A Schematic diagram of the cfDNA analysis workflow. B Correlations between ESR1 template copies/mL plasma and PIK3CA template copies/mL plasma. Kaplan–Meier analysis of PFS by C cfDNA concentration in HR+/HER2− mBC, D cfDNA concentration in HR+/HER2+ mBC, E ESR1 hotspot mutation in HR+/HER2− mBC, and F PIK3CA hotspot mutation in HR+/HER2− mBC. HR, hormone receptor; mBC, metastatic breast cancer; PFS, Progression-free survival